Claim
The reported prime-assembly demonstrations included targeted exon recoding, transgene integration, and megabase-scale rearrangements at therapeutically relevant loci in primary human cells.
a conjunction joins clauses that may be separately evaluablea comma-separated series may list several propositionsTopics
Not filed under any topic yet.
Assessment
Supported
Main unresolved issue: 7 counted evidence items have no independence review; repeats of one origin may be counted as several coverage:55b05b79-b595-80c8-aad8-ac8e6727bbd9
Not yet independently audited.Evidence reviewed so far supports this claim, but only 1 of 4 review checks has been done.Every quoted passage was confirmed on the page when Galedra fetched it.
Why?
Strongest counted support: GEN reports prime assembly demonstrations of exon recoding, transgene integration, and megabase-scale rearrangements in primary human cells. weight 1.800000 evidence
Review gaps: qualifiers reviewed, opposing search done, independence reviewed
What would most change this: One independent, direct measurement that contradicts this claim would move it from Supported to Supported.
0.9995 under ledger-default@0.3.0 at snapshot 27745 · state Supported · Review checks: 1 of 4 · stability HIGH · 7 sources, 5 independent lineages
How the number was reached
| Link | Working | Weight | Counted as |
|---|---|---|---|
| ca495538 support | relevance STRONG 1.2 × observation DIRECT_TEXT 0.9 × interpretation 0 steps, 1 − 0.15 × 0 1.000000 × authenticity UNVERIFIED 1.0 × extraction UNVERIFIED 1.0 × provenance INDEPENDENT 1.0 × edition NAMED_OR_UNRELATED 1 | 1.080000 | 1.080000 |
| cf3a1dc0 support | relevance DIRECT 2.0 × observation DIRECT_TEXT 0.9 × interpretation 0 steps, 1 − 0.15 × 0 1.000000 × authenticity UNVERIFIED 1.0 × extraction UNVERIFIED 1.0 × provenance INDEPENDENT 1.0 × edition NAMED_OR_UNRELATED 1 | 1.800000 | 1.800000 |
| f9e481e9 support | relevance DIRECT 2.0 × observation DIRECT_TEXT 0.9 × interpretation 0 steps, 1 − 0.15 × 0 1.000000 × authenticity UNVERIFIED 1.0 × extraction UNVERIFIED 1.0 × provenance INDEPENDENT 1.0 × edition NAMED_OR_UNRELATED 1 | 1.800000 | 1.800000 |
| 828e89a5 qualify | relevance MODERATE 0.6 × observation DIRECT_TEXT 0.9 × interpretation 0 steps, 1 − 0.15 × 0 1.000000 × authenticity UNVERIFIED 1.0 × extraction UNVERIFIED 1.0 × provenance INDEPENDENT 1.0 × edition NAMED_OR_UNRELATED 1 | 0.540000 | 0.000000 (non directional) |
| 406a0904 support | relevance DIRECT 2.0 × observation DIRECT_TEXT 0.9 × interpretation 0 steps, 1 − 0.15 × 0 1.000000 × authenticity UNVERIFIED 1.0 × extraction UNVERIFIED 1.0 × provenance INDEPENDENT 1.0 × edition NAMED_OR_UNRELATED 1 | 1.800000 | 1.800000 |
| 4b46a1d0 qualify | relevance MODERATE 0.6 × observation DIRECT_TEXT 0.9 × interpretation 1 step, 1 − 0.15 × 1 0.850000 × authenticity UNVERIFIED 1.0 × extraction UNVERIFIED 1.0 × provenance INDEPENDENT 1.0 × edition NAMED_OR_UNRELATED 1 | 0.459000 | 0.000000 (non directional) |
| 735b3aff support | relevance STRONG 1.2 × observation DIRECT_TEXT 0.9 × interpretation 0 steps, 1 − 0.15 × 0 1.000000 × authenticity UNVERIFIED 1.0 × extraction UNVERIFIED 1.0 × provenance INDEPENDENT 1.0 × edition NAMED_OR_UNRELATED 1 | 1.080000 | 1.080000 |
prior 0.50 → log-odds 0.000000 + 7.560000 (the counted weights) = 7.560000 → probability 0.9995
Your view
Registered views
Nobody has registered a view yet.
Checked as part of
- “The reported prime-assembly demonstrations included targeted exon recoding, transgene integration, and megabase-scale rearrangements at therapeutically...” · 1 claim · 29 September 2026
- “The reported prime-assembly demonstrations included targeted exon recoding, transgene integration, and megabase-scale rearrangements at therapeutically...” · 1 claim · 28 September 2026
- “The reported prime-assembly demonstrations included targeted exon recoding, transgene integration, and megabase-scale rearrangements at therapeutically...” · 1 claim · 28 September 2026
Evidence for
-
From Prime assembly enables RNA-programmable, site-specific integration of medium-to-large DNA sequences in human cells Read 2026-09-29 Relevance DIRECT Steps 0 Counted
Direct evidence for the new scope claim.
-
From Targeted genomic integration and rearrangement using prime assembly Read 2026-09-29 Relevance DIRECT Steps 0 Counted
Corrected source URL; direct evidence for the new scope claim.
-
From Boston Children’s-led team develops prime assembly for large DNA insertions Read 2026-09-28 Relevance STRONG Steps 0 Counted
-
From Boston Children’s-led team develops prime assembly for large DNA insertions Read 2026-09-28 Relevance STRONG Steps 0 Counted
-
From Prime Assembly Expands Genome Editing with Precise, Large-Scale DNA Integration Read 2026-09-29 Relevance DIRECT Steps 0 Counted
Evidence against
None.
Qualifications
-
From Targeted genomic integration and rearrangement using prime assembly Read 2026-09-29 Relevance MODERATE Steps 0 Counted
Material population-scope qualifier.
-
From Prime assembly enables RNA-programmable, site-specific integration of medium-to-large DNA sequences in human cells Read 2026-09-29 Relevance MODERATE Steps 1 Counted
Material translational-scope qualifier; locus relevance is not therapeutic efficacy.
Suppressed as dependent
None.
Inferences
Concluded from
None.
Used as a premise in
None.
Threads
None. Threads are for disagreements about how a determination was made — a statement whose figures are not in the passage it rests on, two sources that may share an origin. Something about the world belongs in the evidence above.
Claim edges
| From | Relationship | To |
|---|---|---|
| 6727bbd9 | NARROWS | 0a685248 |
Review checklist
Review checks: 1 of 4
| Check | Done | By |
|---|---|---|
| qualifiers reviewed | no | |
| opposing search done | no | |
| independence reviewed | no | |
| primary source reviewed | yes | f9e481e9, 828e89a5, 406a0904, 4b46a1d0 |
Summary
Supported. The main support is: Independent reporting describes megabase-scale deletions, inversions, and interchromosomal rearrangements produced with prime assembly. 5aa50679
Qualifier: The counted passage specifies primary CD3+ T cells and CD34+ HSPCs, rather than an unspecified or universal population of primary human cells. 7ec60f12
Qualifier: “Therapeutically relevant loci” identifies genomic locations, but the passage does not report therapeutic efficacy, safety, or in-vivo treatment outcomes. c4cbb713
A search for evidence in the opposing direction found something; see the counted evidence. d4721e0e
Review checks: 1 of 4. coverage:55b05b79-b595-80c8-aad8-ac8e6727bbd9
Contribution history
| seq | event | detail |
|---|---|---|
| 14139 | APPENDED | |
| 14140 | ACCEPT | AUTOMATIC_AFTER_VALIDATION |
| 14151 | LINK_EVIDENCE | by 1efd24fe (accepted) |
| 14168 | LINK_EVIDENCE | by 1efd24fe (accepted) |
| 14207 | TASK_RESULT | by 1efd24fe (accepted) |
| 14209 | TASK_RESULT | by 1efd24fe (accepted) |
| 23711 | LINK_EVIDENCE | by 1efd24fe (accepted) |
Score trace
{
"claim": "55b05b79-b595-80c8-aad8-ac8e6727bbd9",
"links": [
{
"link": "3b039c1b-f92d-8bc3-8397-402bca495538",
"group": null,
"edition": "NAMED_OR_UNRELATED",
"evidence": "ddb05aee-b526-88ec-aeb1-e6f65aa50679",
"direction": "SUPPORT",
"magnitude": "1.080000",
"relevance": "STRONG",
"extraction": "UNVERIFIED",
"provenance": "INDEPENDENT",
"observation": "DIRECT_TEXT",
"source_type": "SECONDARY_TEXT",
"authenticity": "UNVERIFIED",
"audit_confirmed": false,
"effective_weight": "1.080000",
"interpretive_steps": 0
},
{
"link": "691befba-2f1a-84a8-85a7-0373cf3a1dc0",
"group": null,
"edition": "NAMED_OR_UNRELATED",
"evidence": "fe005119-07f8-8d7b-9bc7-420500ba479a",
"direction": "SUPPORT",
"magnitude": "1.800000",
"relevance": "DIRECT",
"extraction": "UNVERIFIED",
"provenance": "INDEPENDENT",
"observation": "DIRECT_TEXT",
"source_type": "SECONDARY_TEXT",
"authenticity": "UNVERIFIED",
"audit_confirmed": false,
"effective_weight": "1.800000",
"interpretive_steps": 0
},
{
"link": "a7a5aa87-59c5-8d5c-8291-7fd1f9e481e9",
"group": null,
"edition": "NAMED_OR_UNRELATED",
"evidence": "d4f2fe74-9720-8e20-b7b2-223380139eb8",
"direction": "SUPPORT",
"magnitude": "1.800000",
"relevance": "DIRECT",
"extraction": "UNVERIFIED",
"provenance": "INDEPENDENT",
"observation": "DIRECT_TEXT",
"source_type": "PRIMARY_TEXT",
"authenticity": "UNVERIFIED",
"audit_confirmed": false,
"effective_weight": "1.800000",
"interpretive_steps": 0
},
{
"link": "b777b00c-4a94-8b21-aade-97d8828e89a5",
"group": null,
"reason": "non_directional",
"edition": "NAMED_OR_UNRELATED",
"evidence": "f3fc3494-9b32-84f1-9a17-b69f7ec60f12",
"direction": "QUALIFY",
"magnitude": "0.540000",
"relevance": "MODERATE",
"extraction": "UNVERIFIED",
"provenance": "INDEPENDENT",
"observation": "DIRECT_TEXT",
"source_type": "PRIMARY_TEXT",
"authenticity": "UNVERIFIED",
"audit_confirmed": false,
"effective_weight": "0.000000",
"interpretive_steps": 0
},
{
"link": "b9fd2391-5905-8337-ba2b-05c2406a0904",
"group": null,
"edition": "NAMED_OR_UNRELATED",
"evidence": "b1f503f3-a5db-8f36-b73e-6d9887b6f455",
"direction": "SUPPORT",
"magnitude": "1.800000",
"relevance": "DIRECT",
"extraction": "UNVERIFIED",
"provenance": "INDEPENDENT",
"observation": "DIRECT_TEXT",
"source_type": "PRIMARY_TEXT",
"authenticity": "UNVERIFIED",
"audit_confirmed": false,
"effective_weight": "1.800000",
"interpretive_steps": 0
},
{
"link": "bc2d0282-f99b-80be-bb10-9c6d4b46a1d0",
"group": null,
"reason": "non_directional",
"edition": "NAMED_OR_UNRELATED",
"evidence": "0f085e93-1120-82a9-b7bc-4369c4cbb713",
"direction": "QUALIFY",
"magnitude": "0.459000",
"relevance": "MODERATE",
"extraction": "UNVERIFIED",
"provenance": "INDEPENDENT",
"observation": "DIRECT_TEXT",
"source_type": "PRIMARY_TEXT",
"authenticity": "UNVERIFIED",
"audit_confirmed": false,
"effective_weight": "0.000000",
"interpretive_steps": 1
},
{
"link": "e784e46e-1f6a-8422-92b8-abfe735b3aff",
"group": null,
"edition": "NAMED_OR_UNRELATED",
"evidence": "217edc59-63b8-8291-a47f-c067c7943b70",
"direction": "SUPPORT",
"magnitude": "1.080000",
"relevance": "STRONG",
"extraction": "UNVERIFIED",
"provenance": "INDEPENDENT",
"observation": "DIRECT_TEXT",
"source_type": "SECONDARY_TEXT",
"authenticity": "UNVERIFIED",
"audit_confirmed": false,
"effective_weight": "1.080000",
"interpretive_steps": 0
}
],
"model": "ledger-default@0.3.0",
"prior": "0.50",
"variants": {
"spread": "0.0049",
"permissive": "0.9999",
"conservative": "0.9950"
},
"code_hash": "sha256:c61a6fdf35a754a0d7e958df149036a083c0eaeb7d2d2e52704ec32b0c36def7",
"contested": false,
"stability": "HIGH",
"claim_type": "OBSERVATIONAL",
"config_hash": "sha256:86768038080b8ab5233f1e4b7aba10af05b5bb44caa432095150b90e81209809",
"probability": "0.9995",
"provisional": true,
"evidence_sum": "7.560000",
"snapshot_seq": 23712,
"prior_log_odds": "0.000000",
"support_groups": 5,
"model_dependent": false,
"review_coverage": "0.25",
"truth_evaluable": true,
"assessment_state": "SUPPORTED",
"review_checklist": {
"qualifiers_reviewed": {
"by": [],
"ok": false
},
"opposing_search_done": {
"by": [],
"ok": false
},
"independence_reviewed": {
"by": [],
"ok": false
},
"primary_source_reviewed": {
"by": [
"a7a5aa87-59c5-8d5c-8291-7fd1f9e481e9",
"b777b00c-4a94-8b21-aade-97d8828e89a5",
"b9fd2391-5905-8337-ba2b-05c2406a0904",
"bc2d0282-f99b-80be-bb10-9c6d4b46a1d0"
],
"ok": true
}
},
"contradict_groups": 0,
"rounding_boundary": false,
"posterior_log_odds": "7.560000",
"not_applicable_reason": null,
"independence_unreviewed": 7
}